Elena Pérez Ceballos

9PUBLICATIONS
35CO-AUTHORS
Medical infection agents (incl. prions)Respiratory diseasesCancer therapy (excl. chemotherapy and radiation therapy)Innate immunityHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Apr 10, 2026
Reassessing adverse prognosis of acute myeloid leukemia harboring BCR::ABL1 in the era of tyrosine kinase inhibitors: A real-world analysis from the PETHEMA registry.

Juan M Alonso-Dominguez, Tamara Castaño-Bonilla, Cristina Gil

|Jan 03, 2025
Treatment patterns and outcomes in secondary acute myeloid leukemia arising after hypomethylating agents: PETHEMA registry study.

Pilar Lloret-Madrid, Blanca Boluda, Joaquín Martínez-López

|May 22, 2023
Clinical outcomes after CPX-351 in patients with high-risk acute myeloid leukemia: A comparison with a matched cohort from the Spanish PETHEMA registry.

Teresa Bernal, Ainhoa Fernández Moreno, Almudena de LaIglesia

|Jan 04, 2023
One-year breakthrough SARS-CoV-2 infection and correlates of protection in fully vaccinated hematological patients.

José Luis Piñana, Lourdes Vazquez, Marisa Calabuig

|Jul 28, 2022
Real-life experience of venetoclax and hypomethylating agents in acute myeloid leukemia patients not candidates for intensive chemotherapy or who are refractory/relapsed: A single-centre experience.

Alicia Roldán Pérez, Juan Andrés Vázquez Paganini, M José Penalva Moreno

|May 14, 2022
Azacitidine vs. Decitabine in Unfit Newly Diagnosed Acute Myeloid Leukemia Patients: Results from the PETHEMA Registry.

Jorge Labrador, David Martínez-Cuadrón, Adolfo de la Fuente

Pageof 2

Frequent Collaborators

3 joint publications

Jorge Labrador

2 joint publications

Miguel Ángel Sanz

2 joint publications

Pilar Lloret-Madrid

2 joint publications

Eduardo Rodriguez-Arboli